LOS ANGELES – May 19, 2017 – Ovation Fertility™ is presenting at this week’s annual AAB/CRB conference on how embryo biopsy, preimplantation genetic screening and advances in cryopreservation have led to a more efficient and effective path to pregnancy for patients undergoing in vitro fertilization (IVF) treatment.
Ovation Fertility scientists’ work is being showcased at the annual meeting and educational conference of the American Association of Bioanalysts (AAB) and the College of Reproductive Biology (CRB) today and Saturday (May 19-20) at the Galleria Hotel in Houston. The conference reinforces AAB’s commitment to excellence in clinical laboratory services and regulations.
“We are pleased to share industry-recognized, pioneering IVF research performed by Ovation Fertility and to provide continuing education to clinical and medical laboratory professionals across the nation,” says Nate Snyder, CEO, Ovation Fertility. “Attendees benefit from learning about the successes brought about by the collaborative mindshare of Ovation Fertility IVF and genetics labs, working in tandem with our partner physician practices.”
Mitchel C. Schiewe, Ph.D., HCLD, who directs Ovation Fertility’s IVF lab in Newport Beach, notes that by working together across its network of experts, Ovation Fertility developed reproductive technology solutions that make achieving pregnancy through IVF more effective, affordable and financially accessible.
Ovation Fertility IVF Labs, Partner Practices Join Forces
The two abstracts being presented at the conference show research performed by Ovation Fertility in conjunction its partner physician practices.
1. “Striving for One Embryo-One Baby: How the Integration of Vitrification and Preimplantation Genetic Screening (PGS) Technologies Has Impacted Society”
Technical Supervisor Shane Zozula of Ovation Fertility Newport Beach is presenting a poster based on Ovation Fertility’s founding philosophy to achieve successful pregnancy one healthy baby at a time. Although advanced embryo culturing has led to favorable pregnancy results using fresh embryo transfers, they often were the result of multiple embryo transfers, resulting in high-risk pregnancies with twins and triplets. Through elective vitrification and the adoption of blastocyst biopsy/PGS, Ovation Fertility has improved the quality of patient care by transferring fewer embryos, reducing miscarriages and increasing healthy singleton live births.
The findings were produced collaboratively by researchers at Ovation Fertility labs in Newport Beach and Las Vegas, Southern California Center for Reproductive Medicine, and The Fertility Center of Las Vegas. They include Shane Zozula; John Whitney; Robert E. Anderson, M.D.; and Schiewe. Forest Garner provided study design and statistics support.
2. “Comparative Human Blastocyst Repeat Vitrification (rVTF): Effect of Device Type (Cryolock versus microSecure) by Solution Used (DMSO/EG versus Glycerol/EG) on Post-warming Viability”
Vitrification of human embryos has evolved into a highly reliable and efficient process in many assisted reproductive-technology laboratories worldwide. Over the past several years, Schiewe has strived to better understand the physical and chemical relationships of vitrification treatments by using a revitrification model to define tolerance thresholds for post-warming survival/viability. At the AAB/CRB conference, embryologist RaeAnne vanTol is making the oral presentation showing the resiliency of human blastocysts to various cryopreservation agents and devices. The subset of data being presented is part of a larger collaborative study between Ovation Fertility labs in Newport Beach and Nashville that will be presented at the European Society of Human Reproduction and Embryology annual conference in July.
Additional authors include Shane Zozula, Kelley Waggoner and Schiewe, all of Ovation Fertility Newport Beach.
Collaboration Leads to Success
According to Snyder, “We are proud of the collaborative efforts among Ovation Fertility labs and partner practices. The greatest advances in reproductive medicine result from the collective knowledge and shared experience of fertility professionals, working as a cohesive team rather than as individuals. The research presented by Ovation Fertility in Houston will benefit all patients who are considering using IVF to build their families.”
About Ovation Fertility™
Ovation Fertility – Founded in 2015 by a coalition of thought-leading reproductive endocrinologists and scientists, Ovation Fertility is a national fertility service provider offering a suite of state-of-the-art assisted reproductive technology services to aspiring parents, including embryology, andrology and genetic testing as part of the in vitro fertilization process. Ovation Fertility partners with physicians who are committed to reducing the average cost of a live birth through IVF by advancing industry standards in fertility treatment. For more information, visit www.ovationfertility.com.